Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Sven Plein , , Added: 1 year ago
This breakout session – first broadcast as part of the inaugural New Horizons in Amyloidosis (NHA) meeting, held in February 2024 – is moderated by Dr Timothy Albert (Circle Cardiovascular Imaging), with faculty Dr Kanae Mukai (Salinas Valley Health, US) and Dr Sven Plein (University of Leeds, UK).The session provides insight into the clinical integration of cardiac MRI, supported by practical,… View more
Author(s): Brian Lindman Added: 3 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more
Author(s): Marianna Fontana Added: 7 months ago
AHA Conference 2024 - Safety and efficacy outcomes of nexiguran ziclumeran (NTLA-2001) in patients with transthyretin amyloidosis with cardiomyopathy (ATTR-CM).Dr Marianna Fontana (University College London, London, UK) joins us onsite at AHA Conference to discuss the findings from the nexiguran ziclumeran for ATTR-CM trial (NCT04601051).Dr Fontana discusses a phase 1, ongoing, open-label, single… View more
Research Area(s) / Expertise:

Heart Failure

Cardio-oncology

Amyloidosis

Job title: Consultant Cardiologist, National Amyloidosis Centre & Royal Free London Hospital, University College London, UK
In October 2009, the Royal Free London NHS Foundation Trust hired Dr. Carol Whelan as a consultant cardiologist with expertise in imaging, heart failure, and cardiac amyloidosis. As a result of her efforts at the National Amyloidosis Centre, she has been given the title of Honorary Associate Professor at UCL. In 2011, she was named the hospital's clinical lead for heart failure. In 2018, she was… View more
Professor Thibaud Damy is a cardiologist focusing on heart failure and cardiac amyloidosis. He works at Hospital Henri Mondor and Paris East Creteil University (UPEC), and is part of INSERM U955. Prof Damy leads the Referral Center for Cardiac Amyloidosis and the French National Amyloidosis Network, which includes a registry of about 4,500 patients. View more
Author(s): Diana Hui Ping Foo Added: 2 months ago
ESC HF 25 - Findings from Heart2Miss suggest a hub-and-spoke model for early heart failure detection can detect patients with pre-HF and HF who were previously undiagnosed, can reduce tertiary center overload and improve novice performance.Dr Diana Foo (Sarawak General Hospital, Kuching, MY) discusses the findings from the Heart2Miss study, investigating a decentralised, community-based, rapid,… View more
Author(s): Christophe Leclercq Added: 3 months ago
EHRA 2025 - Outcomes from cardiac resynchronization therapy (CRT) with MultiPoint pacing (MPP) to treat patients who are not responding to standard CRT show that MPP does not improve the conversion rate of non-responders to responders compared to standard CRT; however, a reduction in HF hospitalisation was seen in the group receiving MPP.Prof Christophe Leclercq (Centre Hospitalier Universitaire… View more